CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.

Autor: Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Kusowska A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Zhylko A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Forcados C; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Slusarczyk A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland., Barankiewicz J; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Faculty of Medicine, Lazarski University, Warsaw, Poland., Domagala J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Kubacz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Šmída M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Dostalova L; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Marhelava K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Baranowska I; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Szumera-Cieckiewicz A; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Granica M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Graczyk-Jarzynka A; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Majchrzak M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland., Poreba M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland., Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Peipp M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Prochorec-Sobieszek M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.

Publikováno v: Oncoimmunology [Oncoimmunology] 2024 Jun 04; Vol. 13 (1), pp. 2362454. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).

Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.

Autor: Machnicki MM; Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland., Rzepakowska A; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland., Janowska JI; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Pepek M; Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland., Krop A; Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland., Pruszczyk K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Stawinski P; Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland., Rydzanicz M; Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland., Grzybowski J; Department of Pathology, Medical University of Warsaw, Warsaw, Poland., Gornicka B; Department of Pathology, Medical University of Warsaw, Warsaw, Poland., Wnuk M; Department of Biology, University of Rzeszow, Rzeszow, Poland., Ploski R; Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland., Osuch-Wojcikiewicz E; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Warsaw, Warsaw, Poland., Stoklosa T; Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 May 19; Vol. 12, pp. 768954. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022).

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia-From Single Cell Analysis to Next-Generation Sequencing.

Autor: Deregowska A; Department of Biotechnology, University of Rzeszow, Pigonia 1, 35-310 Rzeszów, Poland.; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a, 02-091 Warsaw, Poland., Pepek M; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a, 02-091 Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland., Pruszczyk K; Department of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland., Machnicki MM; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Trojdena 2a, 02-091 Warsaw, Poland.; Department of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland., Wnuk M; Department of Biotechnology, University of Rzeszow, Pigonia 1, 35-310 Rzeszów, Poland., Stoklosa T; Department of Tumor Biology and Genetics, Medical University of Warsaw, Pawinskiego 7, 02-106 Warsaw, Poland.

Publikováno v: Genes [Genes (Basel)] 2020 Sep 29; Vol. 11 (10). Date of Electronic Publication: 2020 Sep 29.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.